These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 8273362

  • 1. [Interferon--a new therapeutic principle].
    Micksche M.
    Wien Med Wochenschr; 1993; 143(16-17):408-12. PubMed ID: 8273362
    [Abstract] [Full Text] [Related]

  • 2. [Current status of interferon therapy].
    Dittrich C.
    Wien Med Wochenschr; 1986 Apr 30; 136(7-8):163-72. PubMed ID: 2425497
    [Abstract] [Full Text] [Related]

  • 3. Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons.
    Pfeffer LM, Dinarello CA, Herberman RB, Williams BR, Borden EC, Bordens R, Walter MR, Nagabhushan TL, Trotta PP, Pestka S.
    Cancer Res; 1998 Jun 15; 58(12):2489-99. PubMed ID: 9635566
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The interferon system. A review of biological principles and clinical uses].
    Schneider FJ.
    Z Gesamte Inn Med; 1986 Nov 15; 41(22):613-8. PubMed ID: 2436387
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Interferons, a class of cytokines with a large therapeutic activity range].
    Billard C.
    Bull Cancer; 1993 Sep 15; 80(9):741-56. PubMed ID: 7515733
    [Abstract] [Full Text] [Related]

  • 8. Interferon-alpha and cancer: mechanisms of action and new perspectives of clinical use.
    Ferrantini M, Capone I, Belardelli F.
    Biochimie; 2007 Sep 15; 89(6-7):884-93. PubMed ID: 17532550
    [Abstract] [Full Text] [Related]

  • 9. [New aspects of interferon therapy in malignant diseases].
    Micksche M.
    Wien Med Wochenschr; 1993 Sep 15; 143(16-17):454-7. PubMed ID: 7505990
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Alpha interferons--new therapeutic modalities].
    Bajcetić M, Zigon N, Samardzić R, Beleslin DB.
    Med Pregl; 1998 Sep 15; 51(3-4):135-9. PubMed ID: 9611956
    [Abstract] [Full Text] [Related]

  • 12. Induction of differentiation and suppression of malignant phenotype of human neuroblastoma BE(2)-C cells by valproic acid: enhancement by combination with interferon-alpha.
    Cinatl J, Kotchetkov R, Blaheta R, Driever PH, Vogel JU, Cinatl J.
    Int J Oncol; 2002 Jan 15; 20(1):97-106. PubMed ID: 11743648
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW, Li D, McQuone SJ, Ralston R.
    Laryngoscope; 2005 Mar 15; 115(3):391-404. PubMed ID: 15744147
    [Abstract] [Full Text] [Related]

  • 15. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A, Parlato A, Vangieri B, Bresciani M, Derna R.
    Clin Ter; 2006 Mar 15; 157(4):377-86. PubMed ID: 17051976
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells.
    Vitale G, van Koetsveld PM, de Herder WW, van der Wansem K, Janssen JA, Colao A, Lombardi G, Lamberts SW, Hofland LJ.
    Am J Physiol Endocrinol Metab; 2009 Mar 15; 296(3):E559-66. PubMed ID: 19141687
    [Abstract] [Full Text] [Related]

  • 18. Gene Regulation and Clinical Roles for Interferons in Neoplastic Diseases.
    Borden EC.
    Oncologist; 1998 Mar 15; 3(3):198-203. PubMed ID: 10388104
    [Abstract] [Full Text] [Related]

  • 19. Differential effects of type I IFNs on the growth of WC1- CD8+ gamma delta T cells and WC1+ CD8- gamma delta T cells in vitro.
    Tuo W, Bazer FW, Davis WC, Zhu D, Brown WC.
    J Immunol; 1999 Jan 01; 162(1):245-53. PubMed ID: 9886392
    [Abstract] [Full Text] [Related]

  • 20. Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines.
    Chawla-Sarkar M, Leaman DW, Borden EC.
    Clin Cancer Res; 2001 Jun 01; 7(6):1821-31. PubMed ID: 11410525
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.